Fisalaemin
Fisalaemin | |||
---|---|---|---|
Identifikacija | |||
CAS registarski broj | 2507-24-6 | ||
PubChem[1][2] | 17268 | ||
MeSH | |||
ChEMBL[3] | CHEMBL415235 | ||
Jmol-3D slike | Slika 1 | ||
| |||
| |||
Svojstva | |||
Molekulska formula | C58H84N14O16S | ||
Molarna masa | 1265.44 g/mol | ||
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje (25 °C, 100 kPa) materijala | |||
Infobox references |
Fisalaemin je tahikininski peptid dobijen iz Physalaemus žaba. On je blisko srodan sa supstancom P. Njegova struktura je prvi put utvrđena 1964.[4][5]
Poput svih tahikinina, fisalaemin povećava salivaciju, i deluje kao potentan vazodilatator sa hipotenzivnim efektima.[6]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.
- ↑ Erspaemer V, Anastasi A, Bertaccini G, Cei JM (1964). „Structure and pharmacological actions of physalaemin, the main active polypeptide of the skin of Physalaemus fuscumaculatus”. Experientia 20 (9): 489–90. DOI:10.1007/BF02154064. PMID 5857249.
- ↑ Anastasi A, Erspamer V, Cei JM (1964). „Isolation and amino acid sequence of physalaemin, the main active polypeptide of the skin of Physalaemus fuscumaculatus”. Arch Biochem Biophys 108 (2): 341–8. DOI:10.1016/0003-9861(64)90395-9. PMID 14240587.
- ↑ Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V (2002). „The tachykinin peptide family”. Pharmacol Rev 54 (2): 285–322. DOI:10.1124/pr.54.2.285. PMID 12037144. Free full text Arhivirano 2009-06-06 na Wayback Machine-u